OsteoBites S1 Ep19: Jason Yustein, MD, PhD, Modeling & Targeting MYC-Driven Osteosarcoma

MIB Agents OsteoBites S1 Ep19: Modeling & Targeting MYC-Driven Osteosarcoma with Jason Yustein, MD, PhD

The MYC gene has been reported to be amplified in #osteosarcoma and its expression is often up-regulated in osteosarcoma patients. Osteosarcoma patients with MYC expression is associated with poor prognosis. Dr, Yustein's research focus is on targeting MYC Driven OS.

Guest Information:
Jason Yustein, MD, PhD
Texas Children’s Hospital
Associate Professor, Department of PediatricsHematology/Oncology
Baylor College of Medicine
…
Hosted by Ann Graham MIB Agents Founder & President.
…
Register for next week when we will be speaking with
Richard Gorlick, MD
Division Head and Department Chair
University of Texas, MD Anderson Cancer Center
Baylor College of Medicine On “Correlative Science Leading to Active and Emerging Clinical Trials”.
Register: https://bit.ly/MIBobites
...
MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.

What We Do
PROGRAMS:
✨ End-of-Life MISSIONS
✨ Gamer Agents
✨ Agent Writers
✨ Prayer Agents
✨ Healing Hearts Bereaved Parent Support
✨ Ambassador Agents - Peer Support
EDUCATION for physicians, researchers and families:
✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma
✨ MIB Book: Osteosarcoma: From our Families to Yours
RESEARCH:
✨ Annual MIB FACTOR Research Conference
✨ Funding $100,000 annually for OS research
✨ MIB Testing & Research Directory
✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard
....
Kids are still dying with 40+ year old treatments. Help us MakeItBetter.
🔗 https://www.mibagents.org
...
Osteosarcoma, Bone Cancer, Sarcoma, Pediatric Cancer, Childhood Cancer, Cancer, Cancer Research